Insider Shareholders with Direct Ownership of Phio Pharmaceuticals Corp. (PHIO)
This section provides a comprehensive overview of the insiders with direct ownership of Phio Pharmaceuticals Corp. (PHIO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Phio Pharmaceuticals Corp. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gerrit Dispersyn
President & CEO |
204,903 | 8,954 | 212,327 $129,519 | 6 |
Mar 01, 2022
Reduced 4.05%
|
|
Robert J Bitterman
President & CEO |
86,216 | 2,721 | 20,990 $12,803 | 17 |
Jun 07, 2024
Added 4.55%
|
|
H. Paul Dorman
Director |
20,000 | 0 | 20,370 $12,425 | 2 |
Feb 15, 2022
Added 32.93%
|
|
Caitlin Kontulis
Secretary & VP Finance & Admin |
107,100 | 6,519 | 10,643 $6,492 | 9 |
Mar 01, 2024
Reduced 3.05%
|
|
Robert L Ferrara
Director |
31,182 | 0 | 6,000 $3,660 | 7 |
Jun 14, 2023
Added 25.0%
|
|
Geert Cauwenbergh
Director |
21,500 | 0 | 4,235 $2,583 | 3 |
Feb 17, 2023
Added 26.16%
|
|
Jonathan E Freeman
Director |
21,500 | 0 | 3,197 $1,950 | 3 |
Feb 17, 2023
Added 31.94%
|
|
Curtis Lockshin
Director |
21,500 | 0 | 3,197 $1,950 | 3 |
Feb 17, 2023
Added 31.94%
|
|
Patricia A Bradford
Director |
21,500 | 0 | 3,167 $1,931 | 2 |
Feb 17, 2023
Added 32.14%
|